COMMUNIQUÉS West-GlobeNewswire

IBA - Transparency notification
03/06/2019
Louvain-la-Neuve, Belgium, June 03, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA - Publication relative à une notification de transparence
03/06/2019
Louvain-la-Neuve, Belgique, 3 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Total number of shares and voting rights in Zealand Pharma as of May 31, 2019
03/06/2019
Company announcement – No. 18 / 2019 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 Copenhagen, June 3, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen-based [...]
Bhang Chief Operating Officer, Jamie Pearson, to Keynote Los Angeles CannaGather
03/06/2019
Second Generation Cannabis Executive Talks About the Growth of the Industry, Women Working in the Industry, Bhang’s Growing Global Footprint and Celebrity Connections MIAMI, June 03, 2019 (GLOBE NEWSWIRE) -- Bhang [...]
Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials
03/06/2019
CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a new service, Tempus [...]
Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen
03/06/2019
RENSSELAER, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces that all commercial mouse colonies and contract mouse [...]
Mesa Labs Reports Record Revenues and Adjusted Operating Income for Fiscal Year 2019
03/06/2019
LAKEWOOD, Colo., June 03, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income 1 for Fiscal Year 2019 (FY19 [...]
Greystone Health Network Acquires The Ponce Therapy Care Center in St. Augustine
03/06/2019
TAMPA, Fla., June 03, 2019 (GLOBE NEWSWIRE) -- Greystone Healthcare Management Corp., manager of healthcare facilities and home health agencies in Florida, is pleased to announce the addition of The Ponce Therapy Care [...]
Emerald Health Therapeutics participera à des conférences sur l'investissement et l'industrie en juin
03/06/2019
VANCOUVER, Colombie-Britannique, 03 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH; OTCQX : EMHTF) participera à plusieurs conférences sur l'investissement et le l'industrie en [...]
Wildflower Reports 78% Sales Growth in Third Quarter
03/06/2019
VANCOUVER, British Columbia, June 03, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “ Company ” or “ Wildflower ”) is pleased to report its third quarter sales were up by [...]
Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
03/06/2019
– Ceapro at the forefront of pioneering approach with a natural product as add-on therapy to a prescription product – Study evaluating the well-known health claims of beta glucan and its potentially beneficial approach [...]
White-Labeled Version of iSage Rx launched in Brazil in collaboration with Novo Nordisk
03/06/2019
WILMINGTON, Del., June 03, 2019 (GLOBE NEWSWIRE) -- iSage Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, is announcing a collaboration with Novo Nordisk to launch a white-labeled version [...]
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
03/06/2019
SAN DIEGO and TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients
03/06/2019
CPI-0610 showed signals of clinical activity, both as a monotherapy and in combination with ruxolitinib, in refractory myelofibrosis (MF) patients Patients treated with CPI-0610 exhibited improvement in spleen volume, [...]
AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis
03/06/2019
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has [...]
Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
03/06/2019
Generex shareholder dividend follow-up Launch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen Therapeutix Update on NuGenerex Immuno-Oncology Spin-out and dividend shares Pending completion of [...]
Telix Pharmaceuticals to Present at Jefferies Healthcare Conference
03/06/2019
MELBOURNE, Australia and NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic [...]
Vystar Contracts Rubber Expert Ranjit Matthan for Deproteinized Dry Rubber and Latex R&D
03/06/2019
WORCESTER, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Vystar Corp . (OTC Pink: VYST) extended and expanded its multi-year contract with Ranjit K. Matthan, Ph.D., an internationally renowned latex and rubber science expert [...]
Aptose Announces Closing of Public Offering of Common Shares
03/06/2019
SAN DIEGO and TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced the closing of its previously announced underwritten public offering [...]

Pages